Compare MPTI & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MPTI | BIOA |
|---|---|---|
| Founded | 1965 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 304.3M | 255.6M |
| IPO Year | 2022 | 2024 |
| Metric | MPTI | BIOA |
|---|---|---|
| Price | $66.40 | $5.87 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $83.00 | $32.56 |
| AVG Volume (30 Days) | 67.2K | ★ 881.7K |
| Earning Date | 11-11-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 66.21 |
| EPS | ★ 1.07 | N/A |
| Revenue | ★ $54,417,000.00 | $8,995,000.00 |
| Revenue This Year | $11.45 | N/A |
| Revenue Next Year | $12.37 | $97.72 |
| P/E Ratio | $64.40 | ★ N/A |
| Revenue Growth | ★ 11.03 | N/A |
| 52 Week Low | $43.55 | $4.81 |
| 52 Week High | $104.85 | $25.96 |
| Indicator | MPTI | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 38.49 | 42.38 |
| Support Level | $60.13 | $4.81 |
| Resistance Level | $68.71 | $8.53 |
| Average True Range (ATR) | 2.67 | 0.39 |
| MACD | 0.23 | 0.21 |
| Stochastic Oscillator | 24.59 | 67.82 |
M-Tron Industries Inc is an electronic components manufacturer based in the United States. Along with its subsidiaries, the company is engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company serves markets in aerospace and defense, space, and avionics sectors. Its product offerings include microwave and millimeter-wave filters, crystal resonators, clock oscillators, voltage-controlled crystal oscillators, low noise amplifiers, couplers, attenuators, and switches, among others. Geographically, it derives maximum revenue from the domestic market, and the rest from Malaysia, Australia, Greece, and other countries.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.